Back to Search Start Over

Endothelin: a potential modulator of cerebral vasospasm.

Authors :
Asano T
Ikegaki I
Satoh S
Suzuki Y
Shibuya M
Sugita K
Hidaka H
Source :
European journal of pharmacology [Eur J Pharmacol] 1990 Nov 13; Vol. 190 (3), pp. 365-72.
Publication Year :
1990

Abstract

1-(5-Isoquinolinesulfonyl)-homopiperazine, HA1077, is a calcium antagonist with anti-vasospastic properties. This compound blocks intracellular actions of calcium in a variety of experiments. In the present study, we examined the effects of HA1077 on the vascular actions of endothelin, an endothelium-derived vasoactive peptide, in dogs in vitro and in vivo. Intracisternal injections of endothelin (0.01 nmol) produced a significant vasospasm, as measured by angiography, similar to that seen in the canine hemorrhage model. Infusion of HA1077 led to a significant dilatation of the spastic basilar artery in endothelin-treated dogs. The rank order of in vitro contractile activity in canine cerebral arteries was a stable thromboxane A2 analog greater than endothelin greater than 5-hydroxytryptamine greater than prostaglandin F2 alpha greater than histamine greater than noradrenaline. HA1077 effectively antagonized the endothelin-induced contraction of canine basilar arterial strips in both calcium-containing and calcium-free medium. The present results indicate that HA1077 is an effective antagonist for endothelin in vitro and in vivo.

Details

Language :
English
ISSN :
0014-2999
Volume :
190
Issue :
3
Database :
MEDLINE
Journal :
European journal of pharmacology
Publication Type :
Academic Journal
Accession number :
2272374
Full Text :
https://doi.org/10.1016/0014-2999(90)94201-8